JBS is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. Despite some technical weakness, the company's strong financial performance, positive analyst ratings, and favorable options sentiment make it a solid long-term investment opportunity.
The MACD is negatively expanding (-0.154), indicating bearish momentum. RSI is neutral at 29.408, and moving averages are converging, suggesting no clear trend. The stock is trading near its support level (S2: 16.623), which could provide a potential entry point.

Barclays raised the price target to $23, citing solid Q4 performance and healthy cash flow.
UBS initiated coverage with a Buy rating and a $19.50 price target, highlighting potential re-rating post U.S. listing.
Strong revenue growth in Q4 2025 (15.47% YoY).
Gross margin dropped significantly (-16.51% YoY), which could indicate cost pressures.
MACD and RSI suggest technical weakness in the short term.
In Q4 2025, revenue increased by 15.47% YoY to $23.06 billion. Net income rose slightly by 0.55% YoY to $415.14 million. EPS remained flat at 0.37. However, gross margin declined by -16.51% YoY, indicating potential cost management issues.
Analysts are bullish on JBS. Barclays raised the price target to $23 and maintains an Overweight rating. UBS initiated coverage with a Buy rating and a $19.50 price target, citing potential re-rating and unpriced returns from expansion capex.